Amy McBride Wendell, Director at Axogen, Inc. (AXGN), sold 13,353 shares at $48.42 ($647K) on 2026-08-11, disclosed to the SEC on 2026-08-12.
Scheduled sale ($647k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AXGN | SELL | 2025-12-17 | $2.4M | — | Filing → |
| AXGN | SELL | 2025-06-11 | $43K | — | Filing → |
| AXGN | SELL | 2025-03-05 | $100K | — | Filing → |